©The Author(s) 2025.
World J Gastroenterol. Dec 21, 2025; 31(47): 111637
Published online Dec 21, 2025. doi: 10.3748/wjg.v31.i47.111637
Published online Dec 21, 2025. doi: 10.3748/wjg.v31.i47.111637
Table 1 Characteristics of hepatitis B surface antigen +/anti-hepatitis delta virus positive patients by sex, n (%)
| Anti-HDV positive | P value | ||
| Males | Females | ||
| 3161 (61.6) | 1971 (38.4) | 0.738 | |
| Age, median (Q1-Q3) | 56 (48-63) | 56 (45-62) | 0.409 |
| ≤ 40 | 35 (11.1) | 37 (18.8) | 0.143 |
| 41-50 | 59 (18.7) | 38 (19.3) | |
| 51-60 | 114 (36.1) | 58 (29.4) | |
| 61-70 | 85 (26.9) | 50 (25.4) | |
| > 70 | 23 (7.3) | 14 (7.2) | |
| Non-Italian natives | 81 (25.6) | 92 (46.7) | < 0.001 |
| Injection drug use (any time) | 45 (17.3) | 3 (1.7) | < 0.001 |
| ALT > 35 IU/L | 199 (64.8) | 108 (56.5) | 0.065 |
| GGT > 50 IU/L | 116 (46.6) | 44 (27.3) | < 0.001 |
| HBeAg positive | 16 (5.3) | 12 (6.3) | 0.612 |
| HDV RNA positive (n = 430 tested) | 176 (68.0) | 124 (72.5) | 0.314 |
| Cirrhosis | 232 (73.4) | 130 (66.0) | 0.073 |
| Child-Pugh class | |||
| A | 197 (86.8) | 103 (82.4) | 0.231 |
| B | 25 (11.0) | 21 (16.8) | |
| C | 5 (2.2) | 1 (0.8) | |
| MELD ≥ 20 | 6 (3.0) | 0 (0.0) | 0.097 |
| HCC | 40 (12.6) | 11 (5.6) | 0.010 |
| PLT ≤ 150000 | 177 (57.8) | 108 (56.5) | 0.776 |
| Previous IFN | 104 (35.4) | 49 (27.7) | 0.084 |
| Cofactors of liver disease | |||
| BMI 25-30 | 84 (37.8) | 45 (33.1) | 0.124 |
| BMI ≥ 30 | 19 (8.6) | 21 (15.4) | |
| Ongoing alcohol use | 61 (23.0) | 10 (6.1) | < 0.001 |
| Past use | 58 (21.9) | 15 (9.2) | |
| Diabetes | 28 (8.9) | 4 (2.0) | 0.002 |
| Steatotic liver disease | 84 (26.6) | 36 (18.3) | 0.031 |
| Anti-HCV positive (all HCV RNA negative) | 42 (14.7) | 1 (0.6) | < 0.001 |
| Anti-HIV positive | 22 (8.1) | 1 (0.6) | 0.001 |
| NUC treatment | |||
| Ongoing NUC therapy | 234 (74.3) | 138 (70.4) | 0.338 |
| Years of NUC therapy, median (Q1-Q3) | 4.2 (1.7-7.9) | 4.2 (2.0-7.6) | 0.733 |
- Citation: Coco B, Quaranta MG, Tosti ME, Ferrigno L, Brancaccio G, Ciancio A, Coppola C, Messina V, Gentile I, Claar E, Morisco F, Santantonio T, Viganò M, Cacciola I, Pompili M, Russo FP, Izzi A, Niro GA, Coppola N, Soria A, Federico A, Morsica G, Puoti M, Villa E, Lampertico P, Gaeta GB, Kondili LA, Brunetto MR, PITER Collaborating Investigators. Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort. World J Gastroenterol 2025; 31(47): 111637
- URL: https://www.wjgnet.com/1007-9327/full/v31/i47/111637.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i47.111637